Items where authors include "Kennedy, B"

Article

Hillmen, P, Pitchford, A, Bloor, A et al. (29 more authors) (2023) Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology, 24 (5). pp. 535-552. ISSN 1470-2045

Munir, T, Emmerson, J orcid.org/0000-0002-8198-8043, Hockaday, A et al. (9 more authors) (2022) Obinutuzumab as consolidation after chemo-immunotherapy: Results of the UK National Cancer Research Institute phase II/III GALACTIC trial. British Journal of Haematology, 199 (5). pp. 707-719. ISSN 0007-1048

Pettitt, AR, Jackson, R, Cicconi, S et al. (23 more authors) (2020) Lenalidomide, Dexamethasone And Alemtuzumab Or Ofatumumab In High-Risk Chronic Lymphocytic Leukaemia: Final Results Of The NCRI CLL210 Trial. Haematologica, 105 (12). pp. 2868-2871. ISSN 0390-6078

Bestall, JC, Siddiqi, N orcid.org/0000-0003-1794-2152, Heywood Everett, S et al. (6 more authors) (2017) New models of care: a liaison psychiatry service for medically unexplained symptoms and frequent attenders in primary care. BJPsych bulletin. pp. 340-344. ISSN 2056-4694

Bestall, J orcid.org/0000-0001-6765-6379, Siddiqi, N, Heywood-Everett, S et al. (6 more authors) (2017) New models of care: a liaison psychiatry service for medically unexplained symptoms and frequent attenders in primary care. BJPsych Bulletin, 41 (6). pp. 340-344. ISSN 2056-4708

Proceedings Paper

Munir, T, Howard, D orcid.org/0000-0003-3333-9783, McParland, L et al. (10 more authors) (2018) Obinutuzumab as consolidation after chemo-immunotherapy is highly effective in achieving MRD clearance from bone marrow and peripheral blood-Initial results of UK NCRI Phase II/III GALACTIC trial. In: British Journal of Haematology. 58th Annual Scientific Meeting of the British Society for Haematology, 16-18 Apr 2018, Liverpool, UK. Wiley , p. 79.